UMIN-CTR Clinical Trial

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000049649
Receipt No. R000056543
Scientific Title Characteristics of controlled ovarian stimulation by follitropin delta compared with follitropin alpha
Date of disclosure of the study information 2022/12/01
Last modified on 2022/11/30 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Characteristics of controlled ovarian stimulation by follitropin delta compared with follitropin alpha
Acronym Controlled ovarian stimulation by follitropin delta
Scientific Title Characteristics of controlled ovarian stimulation by follitropin delta compared with follitropin alpha
Scientific Title:Acronym Controlled ovarian stimulation by follitropin delta
Region
Japan

Condition
Condition Infertility
Classification by specialty
Obsterics and gynecology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Comparison of clinical performance and follicle development between follitropin delta and follitropin alfa
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Clinical pregnancy rate, follicular growth diameter
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Controlled ovarian stimulation with follitropin delta
Interventions/Control_2 Controlled ovarian stimulation with follitropin alfa
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
25 years-old <=
Age-upper limit
42 years-old >=
Gender Female
Key inclusion criteria Infertility patients receiving assisted reproductive technology
Key exclusion criteria nothing
Target sample size 100

Research contact person
Name of lead principal investigator
1st name Masato
Middle name
Last name Kobanawa
Organization Kobanawa Clinic
Division name Gynecology
Zip code 311-3435
Address 169-3 Tagiya,Omitama-shi,Ibaraki,Japan
TEL 0299-58-3185
Email masato.kobanawa@gmail.com

Public contact
Name of contact person
1st name Masato
Middle name
Last name Kobanawa
Organization Kobanawa Clinic
Division name Gynecology
Zip code 311-3435
Address 169-3 Tagiya,Omitama-shi,Ibaraki,Japan
TEL 0299-58-3185
Homepage URL
Email masato.kobanawa@gmail.com

Sponsor
Institute Kobanawa Clinic
Institute
Department

Funding Source
Organization nothing
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Ethics committee of Kobanawa Clinic
Address 169-3 Tagiya,Omitama-shi,Ibaraki,Japan
Tel 0299-58-3185
Email masato.kobanawa@gmail.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 12 Month 01 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled 56
Results The fertilization rate, the good blastocyst rate and clinical pregnancy rates were no significant difference.
As a characteristic of follitropin delta COS, follicle development was significantly slow.
Results date posted
2022 Year 11 Month 30 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2021 Year 09 Month 17 Day
Date of IRB
2022 Year 01 Month 18 Day
Anticipated trial start date
2021 Year 10 Month 01 Day
Last follow-up date
2023 Year 01 Month 10 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 11 Month 30 Day
Last modified on
2022 Year 11 Month 30 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056543